69 studies found for:    "Bronchiolitis obliterans"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Montelukast in Bronchiolitis Obliterans Syndrome
Conditions: Bronchiolitis Obliterans;   Lung Transplantation;   Graft Rejection
Intervention: Drug: Montelukast
2 Completed Vitamin D in Bronchiolitis Obliterans Syndrome
Conditions: Allograft Rejection;   Lung Transplantation;   Bronchiolitis Obliterans
Intervention: Drug: Vitamin D
3 Active, not recruiting Montelukast to Treat Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans;   Chronic Graft Versus Host Disease;   Leukotriene;   Montelukast;   Stem Cell Transplant
Intervention: Drug: Singular (Montelukast Sodium)
4 Unknown  Characterization of Bronchiolitis-obliterans Syndrome (BOS) Following Lung Transplantation
Conditions: Lung Transplantation;   Bronchiolitis Obliterans Syndrome
Intervention:
5 Completed Clinical Status and Bronchial Inflammation in Patients With Bronchiolitis Obliterans
Condition: Bronchiolitis Obliterans
Intervention:
6 Terminated Efficacy Study of Azithromycin-based Therapy for Bronchiolitis Obliterans
Conditions: Graft vs Host Disease;   Bronchiolitis Obliterans
Intervention: Drug: azithromycin + N-acetylcystein + inhaled corticosteroid
7 Unknown  Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome
Conditions: Lung Transplantation;   Bronchiolitis Obliterans
Intervention: Drug: Cyclosporine A dry powder inhalation (Drug)
8 Completed Effectiveness of Azithromycin Therapy in Improvement of Symptoms and Lung Function in Patients With Bronchiolitis Obliterans After Bone Marrow Transplantation
Conditions: Bronchiolitis Obliterans;   Bone Marrow Transplantation
Interventions: Drug: Azithromycin;   Drug: Placebo tablet
9 Recruiting Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans;   Graft vs Host Disease
Intervention: Drug: Cyclosporine Inhalation Solution
10 Recruiting Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans;   Constructive Bronchiolitis;   Graft Versus Host Disease
Intervention: Drug: Inhaled Cyclosporine Solution
11 Recruiting Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
Condition: Bronchiolitis Obliterans Syndrome (BOS)
Intervention: Drug: Methoxsalen
12 Unknown  A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT
Condition: Steroid-refractory Bronchiolitis Obliterans
Intervention: Drug: Interferon gamma 1b
13 Recruiting Microparticles and Bronchiolitis Obliterans Syndrome
Condition: Bronchiolitis Obliterans
Intervention: Other: Dosage of Microparticles (MPs) in broncho-alveolar lavage fluid (BALF)
14 Completed Fluticasone Propionate, Azithromycin, and Montelukast Sodium in Treating Patients With Bronchiolitis Obliterans Who Previously Underwent Stem Cell Transplant
Condition: Bronchiolitis Obliterans
Interventions: Drug: fluticasone propionate;   Drug: montelukast sodium;   Procedure: pulmonary function testing;   Other: questionnaire administration;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis;   Genetic: protein analysis;   Drug: azithromycin
15 Terminated Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation
Condition: Bronchiolitis Obliterans
Intervention: Procedure: photopheresis
16 Completed Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation
Conditions: Bronchiolitis Obliterans;   Allogeneic Stem Cell Transplantation
Interventions: Drug: Budesonide/formoterol;   Drug: Placebo
17 Terminated L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients
Condition: Bronchiolitis Obliterans
Intervention: Drug: Cyclosporine Inhalation Solution
18 Active, not recruiting A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation
Conditions: Bronchiolitis Obliterans;   Lung Transplantation
Intervention: Other: MSC
19 Recruiting AZD9668, an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Chronic Graft vs Host Disease;   Chronic Graft-Versus-Host-Disease;   Bronchiolitis Obliterans Syndrome
Intervention: Drug: AZD9668
20 Recruiting Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3
Conditions: Bronchiolitis Obliterans;   Sleep Disordered Breathing Central
Intervention: Procedure: Assessment of sleep disorders and treatment if required

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years